Live Breaking News & Updates on Equity Funds Management

Stay updated with breaking news from Equity funds management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

China Digest: Dearer nets $65m; Temasek backs Abiochem


China Digest: Dearer nets $65m; Temasek backs Abiochem
Dearer nets $65m in Series B
Shanghai-headquartered contact lens manufacturer Dearer has raised 420 million yuan ($65 million) in a Series B round of financing. 
State-backed alternative asset manager CITIC Private Equity Funds Management (CPE), Legend Holdings’ investment arm Legend Capital and BioTrack Capital joined the round. Insight Capital made a follow-on investment in the round. 
The company will use the proceeds for R&D and mass production of coloured contact lenses, the company said in a statement. 
Its early-stage investors include Orient Securities, Borchid Capital,  FOF Capital and eyecare service provider Eyebright. 
Temasek invests in Abiochem  ....

Equity Fund Management , Legend Holding , China Merchants Bank Hong , Abiochem Biotechnology Co Ltd , Abiochem Biotechnology , Equity Funds Management , Legend Capital , Biotrack Capital , Orient Securities , Borchid Capital , China Merchants Bank , Hong Kong Based , Southwest China , Highlight Capital , Addor Capital , Langcheng Capital , Haitong Fortis Private Equity Fund Management , புராண வைத்திருத்தல் , சீனா வணிகர்கள் வங்கி ஹாங் , பங்கு நிதி மேலாண்மை , புராண மூலதனம் , ஆரியெஂட் பத்திரங்கள் , சீனா வணிகர்கள் வங்கி , ஹாங் காங் அடிப்படையிலானது , தென்மேற்கு சீனா , முன்னிலைப்படுத்த மூலதனம் ,